Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chris Roome
Erratum To: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Related publications
Cannabis for Multiple Sclerosis
Practical Neurology
Medicine
Neurology
The Influence of Physiotherapy Intervention on Patients With Multiple Sclerosis–related Spasticity Treated With Nabiximols (THC:CBD Oromucosal Spray)
PLoS ONE
Multidisciplinary
Cannabis as a Possible Treatment for Spasticity in Multiple Sclerosis / Kanabis Kao Moguci Tretman U Lecenju Spasticnosti Kod Multiple Skleroze
Serbian Journal of Experimental and Clinical Research
Medicine
Cannabis Use in Multiple Sclerosis: Excited Interest
Canadian Journal of Neurological Sciences
Medicine
Neurology
Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd66 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Cyprus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental